Pelaris, Lorrie-mae B.
HRN: 20-75-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
CEFUROXIME 500MG (TAB)
07/19/2022
07/25/2022
ORAL
500mg
BID
RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes